Alexia Iasonos

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figure S2 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Data from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Figure S1 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Table S2 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• Supplementary Table S1 from A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number–High/p53-Abnormal Endometrial Cancer

  2026-06-15

• The outcomes of secondary cytoreductive surgery in high-grade serous ovarian carcinoma based on distribution of disease recurrence

  Gynecologic Oncology · 2026-04-23

• Impact of CCNE1 amplification on progression-free and overall survival among patients with newly diagnosed ovarian cancer without a BRCA mutation

  Gynecologic Oncology · 2026-04-23

• Adjuvant dostarlimab with pelvic radiation (RT) in locally advanced, mismatch repair-deficient (MMR-D) endometrial cancer (EC): D-RT study

  Gynecologic Oncology · 2026-04-23

• Multimodal predictors of recurrence in patients with germline BRCA1/2-associated ovarian cancer receiving frontline PARP inhibitor maintenance

  Gynecologic Oncology · 2026-04-23

• Predicting overall survival for patients with uterine leiomyosarcoma using clinical molecular profiling

  Gynecologic Oncology · 2026-04-23

• Combination targeted and Hormonal treAtMEnt of Low-gradE serous Ovarian cancer in the upfroNt setting (CHAMELEON)

  Gynecologic Oncology · 2026-04-23

• Prospective study of near-infrared imaging versus near-infrared imaging plus radiocolloid lymphoscintigraphy for sentinel inguinofemoral lymph node detection in vulvar cancer

  International Journal of Gynecological Cancer · 2026-02-01

• Customized early detection of colorectal cancer in Nigeria identifies advanced adenomas and early‐stage disease

  Cancer · 2025-12-22 · 1 citations

• Supplementary Data from MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

  2025-11-25

• PRIMARY ANALYSIS: PHASE II STUDY OF AVUTOMETINIB AND DEFACTINIB IN WOMEN WITH ADVANCED OR RECURRENT GYNECOLOGIC MESONEPHRIC CANCER

  International Journal of Gynecological Cancer · 2025-11-01

• A pilot study of nivolumab in combination with neoadjuvant and post-surgical chemotherapy in newly diagnosed ovarian cancer

  Gynecologic Oncology · 2025-10-31

• Survival outcomes in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer: Does the indication for neoadjuvant chemotherapy matter?

  Gynecologic Oncology · 2025-10-23

• Prognostic value of positive peritoneal cytology in FIGO 2009 stage IA grade 1 endometrioid endometrial cancer

  Gynecologic Oncology · 2025-10-17

• Bringing Trustworthy Artificial Intelligence to the Clinical Forefront at <i>JCO</i> : A Guide for Studies Testing Artificial Intelligence Models

  Journal of Clinical Oncology · 2025-10-02 · 2 citations

• A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes

  Obstetrics and Gynecology · 2025-10-02 · 4 citations